Insmed Inc at JPMorgan Healthcare Conference Transcript
Great. Welcome, everyone. Good afternoon. My name is Jess Fye. I'm the large cap biotech analyst at JPMorgan, and we're continuing the conference today with Insmed.
Good news. We don't have to switch rooms for Q&A this year. So we're all going to stay here after the presentation and go straight into Q&A. If you want to ask a question, there's 2 ways you can do it. You can raise your hand, somebody will bring you a mic or you can type your question into the portal, it'll shoot it to an iPad I'll have up there, and I can read your questions that way.
So with that, let me turn it over to Insmed's CEO, Will Lewis.
Thank you, Jess. One second for a technical adjustment. I'll give you a preview. I'm anxious to share what's going on with the company, but in a moment, I'm going to have to put up our forward-looking slide -- forward-looking statements slide.
I will be making some forward
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
